Stalicla raised €2.1M in a funding round in Jun 2025. The company is based in Genève, Switzerland. Investors in the round: Addex Therapeutics. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
